Pharmacokinetic considerations in obesity (Q77752248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Pharmacokinetic considerations in obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

Blouin RA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Warren GW

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmaceutical Sciences

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

Mortality and weight: insured lives and the American Cancer Society studies

8 December 2019

cites work

1 reference

7 January 2021

Medical hazards of obesity

1 reference

7 January 2021

Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival

1 reference

7 January 2021

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer

1 reference

7 January 2021

Clinical pharmacokinetics of drugs in obesity. An update

1 reference

7 January 2021

Drug pharmacokinetics in the obese

1 reference

7 January 2021

Drug disposition in obese humans. An update

1 reference

7 January 2021

A comparison of the pharmacokinetics of propranolol in obese and normal volunteers

1 reference

7 January 2021

Serum alpha 1-acid glycoprotein and the binding of drugs in obesity

1 reference

7 January 2021

Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects

1 reference

7 January 2021

The Sizes and Numbers of Cells in Visceral Organs in Human Obesity

1 reference

7 January 2021

OBESITY AND CARDIAC PERFORMANCE

1 reference

7 January 2021

Obesity and cardiac function

1 reference

7 January 2021

Effect of obesity on cyclosporine disposition

1 reference

7 January 2021

Thiopental disposition in lean and obese patients undergoing surgery.

1 reference

7 January 2021

Prolonged accumulation of diazepam in obesity.

1 reference

7 January 2021

Partition coefficients and their uses

1 reference

7 January 2021

Digoxin disposition in obesity: Clinical pharmacokinetic investigation

1 reference

7 January 2021

The distribution and concentration of tritiated digoxin in human tissues

1 reference

7 January 2021

Theophylline disposition in obesity

1 reference

7 January 2021

Effect of body weight on the volume of distribution of theophylline

1 reference

7 January 2021

A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects

1 reference

7 January 2021

Tobramycin pharmacokinetics in morbidly obese patients

1 reference

7 January 2021

Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium

1 reference

7 January 2021

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

1 reference

7 January 2021

Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects

1 reference

7 January 2021

Phenytoin disposition in obesity. Determination of loading dose

1 reference

7 January 2021

Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers

1 reference

7 January 2021

Pharmacokinetics and Pharmacodynamics of Triazolam After Two Intermittent Doses in Obese and Normal-Weight Men

1 reference

7 January 2021

Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).

1 reference

7 January 2021

Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism

1 reference

7 January 2021

Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol

1 reference

7 January 2021

Hepatic cytochrome P-4503A (CYP3A) activity in the elderly

1 reference

7 January 2021

Obesity, sex, and acetaminophen disposition

1 reference

7 January 2021

A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man

1 reference

7 January 2021

Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin

1 reference

7 January 2021

Prednisolone disposition in obese men

1 reference

7 January 2021

Significant weight reduction in obese subjects enhances carbamazepine elimination

1 reference

7 January 2021

Carbamazepine pharmacokinetics in obese and lean subjects.

1 reference

7 January 2021

Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.

1 reference

7 January 2021

Lithium pharmacokinetics in the obese

1 reference

7 January 2021

Intravenous ciprofloxacin disposition in obesity

1 reference

7 January 2021

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

1 reference

7 January 2021

Effect of Obesity on Gentamicin Pharmacokinetics

1 reference

7 January 2021

Vancomycin pharmacokinetics in normal and morbidly obese subjects

1 reference

7 January 2021

Cimetidine clearance in the obese

1 reference

7 January 2021

Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat

1 reference

7 January 2021

Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat

1 reference

7 January 2021

Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes.

1 reference

7 January 2021

Glutathione depletion by hyperphagia-induced obesity

1 reference

7 January 2021

The genetics of obesity

1 reference

7 January 2021

Energy balance: role of genetics and activity

1 reference

7 January 2021

Regulation of ob gene expression in rodents and humans

1 reference

7 January 2021

The new obesity genes.

1 reference

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

7 January 2021

The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks

1 reference

7 January 2021

Leptin: genes, concepts and clinical perspective

1 reference

7 January 2021

Leptin: the tale of an obesity gene

1 reference

7 January 2021

Obesity and therapy-related toxicity in patients treated for small-cell lung cancer

1 reference

7 January 2021

Clinical pharmacokinetics of ciprofloxacin

1 reference

7 January 2021

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

1 reference

7 January 2021

Age and renal clearance of cimetidine

1 reference

7 January 2021

Identifiers

DOI

10.1021/JS980173A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874695%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference